Dizal Pharmaceutical
68819253.520.15% ( -0.08 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Dizal Pharmaceutical(688192) the Revenue is 252.52 M (+58.18%);the EBIT is -95.99 M (+49.26%);the EPS is -0.21 (+54.35%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.25B58.18%
----
----
EBIT
-0.10B49.26%
----
----
EPS
-0.2154.35%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf